<DOC>
	<DOCNO>NCT00122317</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety eculizumab patient transfusion dependent hemolytic PNH .</brief_summary>
	<brief_title>Extension Study Eculizumab Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria ( PNH )</brief_title>
	<detailed_description />
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<mesh_term>Hemoglobinuria</mesh_term>
	<criteria>Patients fully complete TRIUMPH , SHEPHERD , X03001 study TRIUMPH patient discontinue receive investigational drug prior last visit study due lack efficacy exacerbation symptom PNH complete monthly safety efficacy procedure Patient must willing able give write informed consent Patient must avoid conception trial Patients terminate early SHEPHERD X03001 study Patients terminate early TRIUMPH study due adverse event Female pregnant , breast feeding , intend conceive course study Any condition could increase patient 's risk participating study could confound outcome study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Transfusion dependent , hemolytic paroxysmal nocturnal hemoglobinuria</keyword>
</DOC>